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Effects of 3 diets with various calcium contents on 24-h energy
expenditure, fat oxidation, and adipose tissue message RNA
expression of lipid metabolism–related proteins1–3
Niels Boon, Gabby BJ Hul, Nathalie Viguerie, Audrey Sicard, Dominique Langin, and Wim HM Saris
ABSTRACT
Background: Evidence from molecular and animal research and
epidemiologic investigations indicates that calcium intake may be
inversely related to body weight, possibly through alterations in
1,25-dihydroxyvitamin D3 [1,25(OH)2D3] metabolism.
Objective: We tested whether energy and substrate metabolism and
adipose tissue enzyme messenger RNA (mRNA) expression can be
altered by dietary calcium intake in healthy, nonobese, human vol-
unteers consuming an isocaloric diet.
Design: Twelve healthy men [age: 28  2 y; body mass index
(BMI; in kg/m2): 25.2  06] received 3 isocaloric diets [high cal-
cium (1259  9 mg/d), high dairy (high/high); high calcium
(1259  9 mg/d), low dairy (high/low); and low calcium (349  8
mg/d), low dairy (low/low)] in a randomized crossover design. At
the end of the 7-d dietary periods, 24-h energy expenditure and
substrate metabolism were measured, and fat biopsy specimens
were obtained to determine mRNA expression in genes involved in
the lipolytic and lipogenic pathways.
Results: The 24-h energy expenditure was 11.8 0.3, 11.6 0.3,
and 11.7  0.3 MJ/24 h in the high/high, high/low, and low/low
conditions, respectively. Fat oxidation in these conditions was 108
7, 105  9, and 100  6 g/24 h. These differences were not statis-
tically significant. mRNA concentrations of UCP2, FAS, GPDH2,
HSL, and PPARG did not differ significantly. Serum 1,25(OH)2D3
concentrations changed from 175  16 to 138  15, 181  23 to
159  19, and 164  13 to 198  19 pmol/L in the high/high,
high/low, and low/low conditions, respectively, and was signifi-
cantly different between the high/high and low/low conditions (P
0.05).
Conclusion: Altering the dietary calcium content for 7 d does not
influence substrate metabolism, energy metabolism, or gene expres-
sion in proteins related to fat metabolism, despite significant changes
in 1,25(OH)2D3 concentrations. Am J Clin Nutr 2005;82:
1244–52.
KEY WORDS Dietary calcium, energy expenditure, adipose
tissue message RNA expression, body weight regulation, substrate
metabolism, 1;25-dihydroxyvitamin D3, 1;25(OH)2D3
INTRODUCTION
The prevalence of obesity has increased markedly during the
past 2 decades, making obesity an important risk factor for the
development of type 2 diabetes, various types of cancer, and
cardiovascular complications. In recent years, an inverse relation
between dietary calcium and body mass index (BMI; in kg/m2)
was repeatedly observed (1–8). Some intervention studies also
showed that dietary calcium may have weight-lowering effects,
and, in addition, an even stronger effect was observed with dairy
sources of calcium (9–12).
However, the mechanism is still unclear. A hypothesis to ex-
plain this relation was provided by Zemel et al (13). With an
increased concentration of 1,25-dihydroxyvitamin D3
[1,25(OH)2D3] in cultures of human adipocytes and in transgenic
mice, acute increases of the intracellular calcium concentration
were observed (14, 15). This increased concentration of Ca2 in
the adipocytes lowered lipolysis and stimulated lipogenesis.
Lowering the intake of dietary calcium leads to an increase in the
serum concentration of 1,25(OH)2D3 within a few days (16). In
this way, a low intake of dietary calcium may lead to a higher
body weight by changing the balance of lipolysis and lipogenesis
in adipose tissue through an increase in serum 1,25(OH)2D3 (1).
Serum 1,25(OH)2D3 is an important regulator of a large num-
ber of genes (17). Of the genes regulated by 1,25(OH)2D3 are
genes that are either related to fat breakdown and storage [HSL
(hormone sensitive lipase), GPDH2 (glycerol phosphate dehy-
drogenase), and FAS (fatty acid synthase)] or adipocyte differ-
entiation [PPARG (peroxisome-proliferator activated receptor
)] (18–22). Furthermore, 1,25(OH)2D3 decreases the messen-
ger RNA (mRNA) expression of UCP2 (23), which is correlated
with basal metabolic rate (18). If changes in serum 1,25(OH)2D3
are paralleled by changes in the expression of these genes, this
may provide more insight on how calcium intake affects body
weight through changes in lipogenesis, lipolysis, and energy
expenditure (EE).
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The first well-controlled experimental trial to look at the ef-
fects of calcium intake on energy and fat metabolism in weight-
stable subjects was published by Melanson et al (9), who ob-
served a positive correlation between 24-h and sleeping fat
oxidation and calcium intake, but they did not correct for protein
intake. Furthermore, in most of the epidemiologic and dietary
intervention studies performed in humans mentioned here, the
investigators did not correct for protein intake (3, 4, 9, 24–26),
which has been shown to have weight-lowering effects (27–31).
These data prompted us to investigate the effect of 3 isocaloric
diets with a fixed macronutrient composition and different con-
centrations of calcium on 24-h EE and 24-h fat oxidation in vivo
in humans. We hypothesized that a higher calcium intake would
increase these indicators and that an additive effect may be ob-
served of low-fat dairy. To study potential effects on a molecular
level, mRNA expression of different genes related to fat metab-
olism (ie, UCP2, FAS, GPDH2, HSL, and PPARG) in adipose
tissue was investigated as well.
SUBJECTS AND METHODS
Experimental subjects
Twelve untrained (did not perform any regular physical activ-
ity3 h/wk), healthy men were recruited for participation in this
study through advertisements in local newspapers. This study
was approved by the local ethical committee of the University of
Maastricht and the Academic Hospital of Maastricht. After the
subjects had received a written and oral explanation of the pro-
cedures to be followed in this project, their informed consent was
obtained. Furthermore, the habitual energy, micronutrient, and
macronutrient intakes of the subjects was assessed by using 3-d
food intake diaries, before the start of the experiment. Subjects
were provided with a digital kitchen balance to allow them to
make a more accurate estimation of their habitual food intake,
and the macronutrient and micronutrient compositions of these
habitual diets was calculated from these food records with the use
of the Dutch food-composition table (32). Habitual physical ac-
tivity of the subjects was also determined to assure that none of
the subjects spent 3 h/wk in heavy physical exercise. Finally,
before the start of the first dietary intervention period, body
composition and maximal aerobic capacity were determined.
Maximal exercise test
At least 1 wk before the first stay in the respiration chamber,
maximum oxygen uptake (V˙ O2max), maximum workload
(Wmax), and maximal heart rate (Hfmax) were measured on an
electronically braked cycle ergometer (Lode Excalibur, Gro-
ningen, Netherlands) during an incremental exhaustive exercise
test. During this test, oxygen uptake was measured by using
indirect calorimetry (Oxycon-; Mijnhardt, Mannheim, Ger-
many), and heart rate was measured with a heart rate monitor
(Polar Sporttester, Polar Electro, Kempele, Finland). Exercise
was started at 100 W for 5 min, and the power output was in-
creased by 50 W every 2.5 min consequently until subjects
reached a heart rate of 160. Thereafter, workload was increased
by 25 W. We instructed our subjects to continue until exhaustion.
To calculate the maximum power output, we used the following
formula:
Wmax  Wout  t/150 W (1)
in which Wout is the highest workload completed by the subject,
t is the time (in sec) performed on the last workload, and W is the
final uncompleted load increment. The maximal power output
was the workload at which subjects had to exercise for 45 min
during their 3 consecutive stays in the respiration chamber.
Body-composition and anthropometric measurements
To assure an accurate description, body composition was de-
termined by using the 3-component model with water by Siri
(33). This method combines determination of total body water
with deuterium dilution and estimation of whole-body density by
underwater weighing. The exact details of this method are de-
scribed in detail elsewhere (34).
Experimental design
All 12 subjects underwent three 7-d dietary interventions in a
randomized, crossover design: a high-calcium, high-dairy (high/
high) diet; a high-calcium, low-dairy (high/low) diet; and a low-
calcium, low-dairy (low/low) control diet. Each diet was fol-
lowed by a washout period of 7–14 d. The subjects consumed
these diets at home during the first 5.5 days of the intervention
periods and during the last 36 h of each dietary intervention,
when the subjects were studied in the respiration chamber.
Blood samples were obtained in the fasted state on the first day
of each dietary intervention period (t 0 d) and on the evening
the subjects entered the respiration chamber in the postprandial
state (t  5.5 d). The final blood sample of each period was
obtained in the fasted state when subjects left the respiration
chamber (t 7 d). Fat biopsies were obtained in the fasted state
at baseline and on the 3 occasions that the subjects left the res-
piration chamber at the end of the 3 dietary intervention periods.
Diets
During the 5.5-d periods preceding their 36-h stay in the res-
piration chamber, subjects were provided with 3 different diets
for consumption at home. All food items were consumed as
breakfast, lunch, dinner, and 3 snacks. From the dinner on day 6
onward, all food was consumed in the respiration chamber. Dur-
ing these experiments in the respiration chamber, subjects re-
ceived breakfast, lunch, and dinner at 0730, 1230, and 1800 and
snacks at 1000, 1500, and 2030. These diets were composed so
that their macronutrient and micronutrient compositions resem-
bled the average consumption in the Netherlands. However, we
choose to use a relatively high-protein content to ensure that the
protein balance was equally positive in all experimental condi-
tions, because a high-protein diet may affect body weight (29).
The macronutrient and micronutrient compositions of these diets
were calculated with the use of the Dutch food-composition table
(32). The energy content of the diets during the first 5.5 d of each
dietary intervention was calculated by using the Harris and Bene-
dict equation (35) for men, multiplying the outcome of this cal-
culation by 1.6 to adjust for daily physical activity.
The characteristics of the experimental isocaloric diets were as
follows. The high-calcium, high-dairy (high/high) diet provided
50% carbohydrate, 20% protein, and 30% fat. Low-fat dairy was
used as the main source of protein. The calcium content of this
diet was 1200–1300 mg/d. The high-calcium, low-dairy (high/
low) diet used nondairy sources of protein (animal and vegetable
protein) to match the contribution to the total energy intake (EI)
of protein, fat, and carbohydrate with that of the high/high diet.
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The calcium content of this diet was increased to the same
amount as that of the high/high diet (ie, 1200–1300 mg/d) by
supplementing with calcium carbonate (CalciChew; Christiaens
BV, Breda, Netherlands) (ie, a nondairy source of calcium). The
low-calcium, low-dairy (low/low) diet was similar to the high/
low diet but without the calcium carbonate supplementation. The
calcium content of this diet was 300–400 mg/d.
Subjects received written and oral instructions every time
when the diets were handed out and a meal-to-meal description
of all food items that were to be consumed. All food items were
weighed and packed at the research facility and were handed out
to the subjects on days 1 and 4 of the dietary intervention periods.
Subjects were instructed to write down all deviations from the
diets and to report all problems immediately to the researcher.
Furthermore, compliance to the diets was also checked with
interviews; subjects were also instructed to return all the items
they did not consume on the evening they reported to the labo-
ratory for their 36-h stay in the respiration chamber. These re-
turned food items were not included in the calculation of the total
dietary intake during the experimental periods. In general, no
serious deviations from the diets were reported; that is, these
deviations did not affect the macronutrient composition and cal-
cium content of the diets.
Because it has been shown that deviations from energy balance
(ie, the absolute difference between EI and EE) can significantly
alter substrate metabolism (36), it was assured that the subjects
were in energy balance (here defined as a maximal difference
between EI and EE of0.5 MJ/24 h) during the measurements
of 24-h EE and fat oxidation. To achieve this, at 0700, sleeping
metabolic rate (SMR; defined as the lowest mean EE during 3
consecutive hours between 2300 and 0700) during the first night
was calculated as previously described by Schrauwen et al (37)
and multiplied with a physical activity index (PAI) of 1.7, which
is an activity level that was observed previously in studies with
a comparable exercise regimen (38). Furthermore, at 1600 and
2000, EE was calculated again to adjust EI.
Indirect calorimetry
A respiration chamber was used to accurately determine EE
and substrate oxidation (39). This respiration chamber is a 14-m3
room equipped with a bed, chair, radio, telephone, intercom, a
computer with Internet connection, sink, and toilet. Furthermore,
the air in the respiration chamber is ventilated at a rate of 70–80
L/min. This ventilation rate is measured with a dry-gas meter
(Schlumberger, type G6, The Hague Netherlands). The concen-
trations of oxygen and carbon dioxide are measured by using
paramagnetic oxygen analyzers (type Magnos G6; Hartmann &
Braun, Frankfurt, Germany; type OA 184A; Servomex East Sus-
sex, United Kingdom) and infrared carbon dioxide analyzers
(type Uras 3G; Hartmann & Braun). During each 15-min period,
6 samples of outgoing air for each chamber, one sample of fresh
air, zero gas, and calibration gas are measured. The gas samples
to be measured are selected by a computer, which also stores and
processes the data.
Calculations
The 24-h EE was calculated from V˙ O2 and V˙ CO2 values ob-
tained in the period from 0700 until 0700 the next day with the use
of the Weir formula (40). With the data on urinary nitrogen losses
(described in “Biochemical methods”), these V˙ O2 and V˙ CO2
values were used to calculate carbohydrate, fat, and protein ox-
idation with the following equations of Brouwer (41):
Protein oxidation (g/d) 6.25  N (2)
Fat oxidation (g/d) 
1.718  V˙ O2 1.718  V˙ CO2 0.315  P (3)
Carbohydrate oxidation (g/d) 
4.17  V˙ CO2 2.965  V˙ O2 0.390  P (4)
where N is the total nitrogen excreted in urine (in g/d), V˙ O2 is the
oxygen consumption (in L/d), V˙ CO2 is the carbon dioxide pro-
duction (in L/d), and P is protein oxidation (in g/d). Conse-
quently, substrate balances were calculated by subtracting the
calculated values of macronutrient oxidation from the calculated
intake of these macronutrients during the 24-h stay in the respi-
ration chamber.
At daytime, subjects were instructed not to perform any stren-
uous exercise apart from the 45 min of moderate intensity [50%
of maximal workload (Wmax)] cycling exercise at 1100. Further-
more, they were told not to sleep at daytime. They were asked to
go to bed at2300 throughout all 3 respiration chamber exper-
iments, and they were woken up at 0700.
EE and substrate oxidation were calculated. The 4 individual
periods included SMR [defined as the lowest mean EE during 3
consecutive hours between 2300 and 0700; respiratory quotient
(RQ) was also determined during this period], EE and substrate
oxidation during sleep (EEsleep and RQsleep, defined as the aver-
age EE and RQ values from 2300 until 0700), resting EE and RQ
(EErest and RQrest, defined as the average EE from 0700 until
2300, except for the 45 min of exercise), and EE and RQ during
exercise (EEexercise and RQexercise, defined as the average EE and
RQ during exercise at 50% Wmax).
Finally, the PAI was also calculated for the 3 different exper-
iments in every subject. This was done by dividing the 24-h EE
by the SMR during the second night of the respiration chamber
measurements. For a schematic representation of these measure-
ment periods, see Figure 1.
Biochemical methods
After blood samples were drawn, they were centrifuged at
4000 g for 10 min at 4 °C; aliquots of EDTA plasma and serum
were frozen in liquid nitrogen and stored at	80 °C until further
analysis. Total plasma free fatty acid (FFA), glucose, free glyc-
erol, and Ca2 concentrations in the blood samples were mea-
sured by using standard enzymatic techniques automated on Co-
bas FARA and MIRA centrifugal analyzers at 340 nm (for FFA:
FFA-C test kit, Wako Chemicals, Neuss, Germany; for glucose:
Roche Unikit III, Hoffman-LaRoche Inc, Basel, Switzerland; for
free glycerol: Roche Molecular Biochemicals, Mannheim, Ger-
many; for Ca2: Calcium CP, ABX Pentra, Montpellier, France).
Plasma insulin was measured by using a specific double antibody
radioimmunoassay for human insulin (Kabi Pharmacia, Uppsala,
Sweden), and 1,25(OH)2D3 was measured by using a monoclo-
nal antibody radioimmunoassay (ImmunoDiagnostic Systems
Ltd, Boldon, United Kingdom).
To allow us to calculate nitrogen excretion, 24-h urine was
collected while the subjects were in the respiration chamber from
the second voiding on the first morning until the first voiding on
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the second morning in containers with 10 mL of a 4 mol H2SO4/L
solution to prevent nitrogen losses through evaporation. Volume
of the 24-h urine was measured, and samples of the 24-h urine
were stored at	20 °C until later analysis for nitrogen content.
Quantification of messenger RNAs in biopsies of human
adipose tissue by using reverse transcriptase–quantitative
polymerase chain reaction
After fat biopsies were obtained by using a percutaneous nee-
dle attached to a vacuum syringe, blood and connective tissue
were washed off with a sterile 0.9% NaCl solution. Fat tissue was
weighed and homogenized in 1 mL of a 1% solution of
-mercaptoethanol in RLT buffer (RNeasy Mini kit; Qiagen,
Courtaboeuf, France) per 1000 mg fat tissue, frozen immediately
in liquid nitrogen, and stored at 	80 °C until further analysis.
Total RNA was extracted from adipose tissue biopsies by using
the RNeasy Mini kit (Qiagen). First-strand complementary DNA
(cDNA) was first synthesized from 200 ng total RNA in the
presence of 100 U Superscript II reverse transcriptase (Invitro-
gen, Cergy Pontoise, France) by using random hexamer primers
(Promega, Charbonnières, France). Real-time quantitative poly-
merase chain reactions (qPCRs) were performed on a GeneAmp
7000 Sequence Detection System (Applied Biosystems, Foster
City, CA). cDNA (10 ng) was used as a template for real-time
PCR. The thermal cycler limits for the real-time PCR were 2 min
at 50 °C followed by 40 cycles with 10 s at 95 °C and 1 min at
60 °C. For each primer pair, a standard curve was obtained by
using serial dilutions of human adipose tissue cDNA before
mRNA quantitation. For HSL a set of primers (Genset; Proligo
France, Paris, France) was designed by using the software Primer
Express 1.5 (Applied Biosystems) and used at a final concentra-
tion of 900 nmol/L with SYBR-Green–based chemistry. A dis-
sociation curve was generated at the end of the PCR cycles to
verify that a single gene product was amplified. For UCP2, FAS,
GPDH2, and PPARG the Taqman approach was used. Both
primers and TaqMan probes were obtained from Applied Bio-
systems. The probes were labeled with a reporter dye (FAM) on
the 5' end. The probe for 18S ribosomal RNA was labeled with
the reporter dyes VIC and TAMRA (Applied Biosystems) on the
5' end and the 3' end, respectively. For Taqman assays, because
of the high specificity of the method, a check for nonspecific
product formation with dissociation curve is not needed. We used
18S rRNA as control to normalize gene expression by using the
Ribosomal RNA Control TaqMan Assay kit (Applied Biosys-
tems). All reactions were performed in duplicate.
Statistical analysis
Statistical power analysis by using the variance data from
previously published, similar research, in which a SEM of the
24-h EE of 0.4 MJ and a SEM of the 24-h RQ of 0.01 were
observed (42), indicated that a minimum of 12 subjects was
required to detect a 0.02 decrease in RQ values and a 10% in-
crease in EE between the high/high and low/low diets at a sig-
nificance level of 95%. This would represent a difference in fat
oxidation of20 g/d and a difference in EE of1200 kJ/d at an
EE level of 12 MJ/d. These differences in RQ values and EE were
based on the results of Melanson et al (9) who found even stron-
ger effects of acute calcium intake on 24-h fat oxidation in a less
well-controlled study.
Possible significant differences in substrate and energy me-
tabolism induced by the 3 different diets were calculated by using
a 2-factor analysis of variance (ANOVA), and a Scheffé test was
used for post hoc analysis. Differences over time for the serum
1,25(OH)2D3 concentration were tested for significance with an
ANOVA repeated measures analysis. When a significant group
 time interaction was observed, a Scheffé post hoc analysis was
used to determine the differences among the 3 dietary conditions
on specific time points. Statistical difference was set at P 0.05.
FIGURE 1. Schematic representation of different periods of measurements of energy and substrate metabolism and timing of meals and snacks in the
respiration chamber.
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All data are presented as means SEMs. SPSS for WINDOWS
version 12.0.1 (Chicago, IL) was used for the statistical analysis.
RESULTS
Subject characteristics
The average age of the subjects was 28  8 y. The average
BMI was 25.2  0.6 (Table 1).
Habitual dietary intake
The subjects had an average energy consumption of 12.61.0
MJ/d, which was consumed as 14.80.9% protein, 45.92.8%
from carbohydrate, and 35.7 2.2% from fat. The habitual daily
calcium intake of these subjects was 1027  82 mg, and the
dietary fiber intake of the subjects was 21.2 1.9 g/d (Table 2).
Experimental diets
All subjects completed the 3 different dietary regimens with-
out any adverse effects of the diets, except for 1 subject who
reported after his first 5.5-d dietary run-in (high/low diet) that he
had not consumed all of the food items provided, because he felt
he was overeating. Because the macronutrient composition and
calcium content of the diet he had consumed were in line with the
experimental diets, the data from this experiment were included
in the final analysis. His EI during the 2 following dietary inter-
vention periods was adjusted according to his EE during the first
respiration chamber experiment. The average EI during the 7
days of the dietary interventions was 12.3 0.3, 12.0 0.6, and
12.3 0.3 MJ/d for the high/high, high/low, and low/low diets,
respectively. The experimental diets only differed in calcium
concentration (P  0.0001, low/low compared with high/high
and high/low). All of the experimental diets provided signifi-
cantly more dietary fiber and carbohydrates (P  0.0001) and
significantly less fat (P 0.01) than the subjects’ habitual diets
(Table 2). The high-calcium diets provided significantly more
calcium than the habitual diet (P  0.01), and the low-calcium
diet provided significantly less calcium (P 0.0001). The con-
tent of energy and protein was not significantly different among
any of the diets (Table 2). The dietary tool that was used in the
present investigation does not allow for an accurate determina-
tion of vitamin D intake, but the average intake was168 IU/d
during the 3 experimental diets, whereas the habitual intake was
28  8 IU/d. This difference between the experimental and
habitual diets was not statistically significant. To test whether the
order in which the diets were given had an effect on the mea-
surements of energy and substrate metabolism, all analyses were
also performed with order of diet as a factor. No effects of order
of the dietary intervention were observed.
Metabolic measurements
In all experiments, energy balance was achieved [(EI	EE)
0.5 MJ]. On average, the absolute deviation from energy balance
was 0.2 0.0 MJ/d (high/high), 0.3 0.1 MJ/d (high/low), and
0.2  0.1 MJ/d (low/low) during the 24-h measurements in the
respiration chamber. The total 24-h EE was 11.8 0.3, 11.6
0.3, and 11.7  0.3 MJ/24 h in the high/high, high/low, and
low/low conditions, respectively. These differences were not
statistically different. The EE during the other periods (EESMR,
EEsleep, EErest, and EEexercise) and the PAI were not statistically
different either (Table 3).
The average 24-h RQ was 0.85  0.01, 0.85  0.01, and
0.86  0.01, and the average 24-h fat oxidation in the 3 condi-
tions was 108  7, 105  9, and 100  6 g/d in the high/high,
high/low, and low/low conditions, respectively (Figure 2).
These differences were not statistically different. The average
RQ during SMR in the 3 different dietary conditions was not
statistically different either (0.82  0.01, 0.81  0.02, and
0.82  0.01, respectively). No significant differences in RQ
were observed during the other periods (sleep, rest, or exercise)
(Table 3).
TABLE 1
Physical characteristics of the male subjects1
Value
Age (y) 28 2 (20–40)
Height (m) 1.78 0.02 (1.65–1.92)
Weight (kg) 80.0 0.6 (65.5–95.9)
BMI (kg/m2) 25.2 0.6 (21.2–27.9)
Body fat (%) 22.1 1.6 (9.0–31.9)
Wmax (W) 271 9 (233–336)
V˙ O2max (L/min) 3.5 0.1 (3.0–4.5)
Hfmax (bpm) 193 3 (175–203)
1,25(OH)2D3 (pmol/L) 193 27 (119–447)
1 All values are x SEM; range in parentheses; n 12. Wmax, maximal
workload; V˙ O2max, maximal oxygen consumption; Hfmax, maximal heart
rate; bpm, beats per minute; 1,25(OH)2D3, baseline serum concentration of
1,25-dihydroxyvitamin D3.
TABLE 2
Energy intake, macronutrient composition, and content of calcium and dietary fiber in the habitual and experimental diets during the 7-d intervention1
Diet
Habitual High/high High/low Low/low
Energy intake (MJ/d) 12.6 1.0 12.3 0.3 12.0 0.6 12.3 0.3
Protein (% of energy) 14.8 0.9 19.9 0.1 19.7 0.1 19.8 0.1
Carbohydrate (% of energy) 45.9 2.82 50.0 0.1 49.9 0.1 49.9 0.1
Fat (% of energy) 35.7 2.23 29.9 0.1 30.2 0.1 30.1 0.1
Calcium (mg/d) 1027 82 1259 94,5 1259 94,5 349 86
Dietary fiber (g/d) 21.2 1.92 34.7 1.5 35.4 1.1 31.2 1.0
1 All values are x  SEM; n 12. Differences between the 4 diets were tested with a 2-factor ANOVA; a Scheffé test was used for post hoc analysis.
2,3 Significantly different from all experimental diets: 2 P 0.0001, 3 P 0.01.
4,6 Significantly different from the habitual diet: 4 P 0.01, 6 P 0.0001.
5 Significantly different from the low/low diet, P 0.0001.
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Because of the relatively high intake of dietary protein, a
positive 24-h protein balance (47.5  4.6, 40.3  4.4, and
38.7 5.0 g in the high/high, high/low, and low/low conditions,
respectively) was observed in all 3 experimental conditions. The
24-h fat balance was 	16.1  6.0, 	10.3  7.6, and 	8.4 
5.2 g in the high/high, high/low, and low/low conditions, respec-
tively, and 24-h carbohydrate balance was 11.6 15.2, 29.6
19.6, and 8.6  14.1 g in the high/high, high/low, and low/low
conditions, respectively. No significant differences in substrate
balance were observed among the 3 diets (Table 3).
No differences among the 3 diets were observed in the con-
centrations of plasma calcium, FFA, glucose, insulin, or glyc-
erol. All values were within the normal range. The serum
1,25(OH)2D3 concentrations at t 0 were not significantly dif-
ferent among the 3 interventions. The serum concentration of
1,25(OH)2D3 decreased from 175  16 to 138  15 pmol/L
during the high/high condition, decreased from 181  23 to
159 19 pmol/L in the high/low condition, and increased from
164  13 to 198  19 pmol/L in the low/low condition. A
significant group  time interaction was observed (P  0.05).
The serum concentration of 1,25(OH)2D3 was significantly dif-
ferent between the high/high and low/low conditions at t  7
(P  0.05). Furthermore, the change in serum 1,25(OH)2D3
concentration was 	39  13, 	22  27, and 33  15 pmol/L
for the high/high, high/low, and low/low conditions, respec-
tively. The difference in change was significantly different be-
tween the high/high and low/low conditions (P  0.05). No
differences were observed among the high/low and the other 2
conditions (Figure 3).
The mRNA concentrations in adipose tissue were determined
for 10 subjects only, because for 2 subjects, no complete sets of
biopsies could be obtained because of their relatively low per-
centage of body fat. No differences were observed in the mRNA
concentration of UCP2, FAS, GPDH2, HSL, or PPARG among
the 3 diets (Figure 4).
DISCUSSION
In this carefully controlled dietary intervention study, no dif-
ferences in energy or substrate metabolism were observed among
3 diets with varying contents of calcium and dairy protein, despite
significant changes in the concentration of serum 1,25(OH)2D3.
We did not see any differences in gene expression of 5 genes
involved in the lipogenic and lipolytic pathways.
Because some epidemiologic investigations do show the long-
term effects of an altered Ca2 intake, it may be argued that the
TABLE 3
Different components of energy expenditure (EE)1
Diet
High/high High/low Low/low
EE (kJ/min)
24-h EE 8.19 0.21 8.04 0.20 8.11 0.20
EEsleep 5.58 0.16 5.54 0.13 5.55 0.16
EErest 8.04 0.22 7.86 0.21 7.86 0.19
EEexercise 40.24 1.36 38.45 1.47 39.39 1.39
PAI 1.60 0.02 1.59 0.03 1.61 0.04
RQ
24-h RQ 0.85 0.01 0.85 0.01 0.86 0.01
RQsleep 0.81 0.01 0.82 0.01 0.83 0.01
RQrest 0.87 0.01 0.87 0.01 0.87 0.01
RQexercise 0.90 0.01 0.90 0.01 0.91 0.01
Absolute deviation from energy balance (MJ/24 h)
Energy intake (MJ) 11.7 0.3 11.6 0.3 11.6 0.3
EE (MJ) 11.8 0.3 11.6 0.3 11.7 0.3
Absolute deviation2 0.2 0.0 0.3 0.1 0.2 0.1
Substrate balances (g/24 h)
Protein 47.5 4.6 40.3 4.4 38.7 5.0
Fat 	16.1 6.0 	10.3 7.6 	8.4 5.2
Carbohydrate 11.6 15.2 29.6 19.6 8.6 14.1
1 All values are x SEM; n 12. Differences between the 3 diets were tested with a 2-factor ANOVA; a Scheffé test was used for post hoc analysis. None
of the differences were statistically significant. PAI, physical activity index; RQ, respiratory quotient.
2 Energy intake minus EE.
FIGURE 2. Mean (SEM) 24-h fat oxidation calculated from the indirect
calorimetry values. The data were corrected for protein oxidation, which was
calculated from 24-h nitrogen excretion in urine. n  12. Differences be-
tween the 3 diets were tested with a 2-factor ANOVA; a Scheffé test was used
for post hoc analysis. None of the differences were statistically significant.
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duration of the intervention period was not long enough to induce
the necessary adaptations of the 1,25(OH)2D3 metabolism. How-
ever, we observed significant differences among the 3 diets for
this hormone within 7 d, which is in line with previous research
(43). This hormone was shown to have immediate effects on
lipolysis (22, 23, 44, 45), so the significant changes in
1,25(OH)2D3 that were observed in this study should have in-
duced the metabolic changes that we hypothesized. Nonetheless,
other adaptations to a diet of high calcium and dairy may also
occur that take longer than 7 d. The short duration of this inter-
vention trial did not allow us to measure the effects of such
longer-term adaptations.
It may also be argued that we studied the effects of calcium
depletion rather than the effects of calcium supplementation be-
cause of the already high and possibly optimal calcium intake of
our subjects. But this is contradicted by our data, because both the
high/high and low/low conditions induced a significant change
from the baseline values of the serum 1,25(OH)2D3 concentra-
tion in these subjects with a habitual intake of high calcium.
Along with the results from 2 other recent investigations in which
no relation between 1,25(OH)2D3 and body weight was observed
(46, 47), our results indicate that the 1,25(OH)2D3 metabolism
may not play a significant role in the relation of calcium with
body weight, which is not in line with previous studies that
investigated the relation among calcium intake, 1,25(OH)2D3,
and substrate and energy metabolism (4, 10, 48–50).
However, part of this research that shows significant effects of
altering calcium intake on body weight was performed in ro-
dents, and the results may not carry to the human situation. The
high-calcium diet induced a 1.2-fold increase in calcium intake,
whereas increases of up to 2-fold were observed in the animal
studies (11, 12). Furthermore, the results of the various experi-
ments performed in cell cultures are not directly applicable to
whole-body human metabolism because the intracellular cal-
cium concentrations in these experiments (14, 22, 23, 45, 51, 52)
were manipulated directly by calcium channel and vitamin D
receptor agonists and not through an altered dietary intake of
calcium. Therefore, they do not reflect the normal physiologic
situation. Thus, it seems that the results from these cell culture
and animal studies are not directly applicable to the human in
vivo situation.
An explanation for the discrepancy with the observational
research and our results may be that because of the larger statis-
tical power in epidemiologic investigations, the differences in
body weight and body composition caused by subtle differences
in energy and substrate metabolism that are expected from
changes in calcium intake are more likely to be detected (3, 4, 25,
26, 53–58). Recently, Jacobsen et al (59) did not observe any
differences in substrate and energy metabolism either, using a
comparable study design. From a post hoc power analysis, it was
calculated that to reach significant differences in EE with the
variance and differences observed between groups in the present
investigation, we should include at least 43 subjects. This shows
that 7-d changes in dietary calcium content may not have a robust
effect on either EE or fat oxidation, which is in line with recent
work from Shapses et al (60). However, if the observed differ-
ences would sustain for a prolonged period, they may contribute
to a significant effect on body weight. For example, if the effects
FIGURE 3. Mean (SEM) serum concentrations of 1,25-
dihydroxyvitamin D3 [1,25(OH)2D3] during the 7-d intervention period. n
12. Differences over time between the 3 diets were tested for significance
with a repeated-measures ANOVA. A Scheffé post hoc was used to deter-
mine differences between the 3 dietary conditions on different time points. A
significant group time interaction was observed (P 0.05). #Significantly
different from the low-calcium, low-dairy diet, P 0.05.
FIGURE 4. Mean (SEM) changes in messenger RNA (mRNA) expression of adipose tissue UCP2 (uncoupling protein 2), FAS (fatty acid synthase), HSL
(hormone sensitive lipase), PPARG (peroxisome-proliferator activated receptor ), and GPDH2 (glycerol phosphate dehydrogenase) genes relative to the
prediet value, which was set at 1.00. n 10. Differences between the 3 diets were tested with a 2-factor ANOVA; a Scheffé test was used for post hoc analysis.
None of the differences were statistically significant.
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on fat oxidation observed in this project would last for 1 y, they
may account theoretically for a difference in body weight of3.0
kg (assuming an additional fat oxidation of 8 g/d and with the
assumption that an additional 38000 kJ needs to be expended to
lose 1 kg body fat). An impairment of fat oxidation is suggested
as an important prerequisite to become obese (61). This may be
the link with the observed correlations between calcium intake
and obesity in the epidemiologic studies.
Nonetheless, data from 2 interventional studies indicate a pos-
sible role for calcium in body weight regulation. In one human
intervention trial, an additive effect of increasing dietary calcium
intake on weight loss was observed (50). However, the endpoint
of that experiment was body weight and not substrate metabo-
lism. Furthermore, the subjects were obese, and it was previously
shown that obese subjects show a larger increase in serum
1,25(OH)2D3 in response to a low-calcium diet (16). In another
human intervention study, Melanson et al (9) observed a relation
between acute Ca2 intake and fat oxidation in normal weight
subjects who consumed an energy-balanced diet. The correlation
between acute Ca2 intake and fat oxidation was rather weak
with r2 ranging from 0.32 to 0.38 (P  0.03–0.07), and food
intake was not as well controlled as in the present randomized
clinical trial. Furthermore, in the interventional study by Melan-
son et al (9) and also some other previously published observa-
tional studies (3, 4, 24–26), an increased protein intake that is
related to an increase in calcium intake may have confounded the
outcome measures. Although those 2 intervention studies may
point at an effect of calcium intake on energy and substrate
metabolism, differences in methods and subjects make it difficult
to compare them with the present study.
An alternative mechanism that may be responsible for the
observed epidemiologic relation between dairy and calcium in-
take and body weight is a reduced fat absorption from the gut
induced by an increased calcium intake. In a recent investigation
Jacobsen et al (59) observed that increasing the dietary calcium
intake from 675 to 1850 mg/d induced no differences in energy
or substrate metabolism but a rather large increase of the fecal fat
excretion of 8.2 g/d (from 6.0 to 14.2 g/d). Papakonstantinou et
al (62) also showed in rats that increasing the dietary calcium
intake decreased the energy that was available from the diet from
94% to 90%. Although the magnitude of these results is not in line
with previous research showing more modest effects of dietary
calcium on fat absorption (63, 64), it is clear that fat absorption
may be an important mechanism by which calcium intake can
influence body composition.
Summarizing the results from this investigation, we have
shown that a 7-d dietary intervention with either a high- or a
low-calcium diet induces significant changes in the concentra-
tion of serum 1,25(OH)2D3. However, these changes were not
accompanied by differences in energy and substrate metabolism
or alterations in the mRNA concentration of 5 genes involved in
fat and substrate metabolism, which is in contrast with previous
data. Possible explanations for this discrepancy are first that we
have successfully corrected for the confounding effects of pro-
tein intake. Second, the power of the present investigation may be
too small to detect differences in energy and substrate metabo-
lism induced by different concentrations of dietary calcium.
Finally, the results from other investigations (59, 63–65) also
seem to indicate that the relation between intake of dairy and
calcium and body weight that was observed in epidemiologic
reports may not be mediated by 1,25(OH)2D3 but by other mech-
anisms, for example, the decreased fat absorption that is related
to an increased calcium intake. This mechanism indeed warrants
further investigation.
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